OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Release Date
2023
(3)
2022
(3)
2021
(2)
2025
(1)
2019
(1)
2018
(1)
2014
(1)
2010
(1)
2009
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Cytoplasmic Ig-domain proteins: cytoskeletal regulators with a role in human disease.
Not available
S-EPMC2735333
|
biostudies-literature
Cite
Tumor-Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma.
Not available
S-EPMC6771166
|
biostudies-literature
Cite
Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.
Not available
S-EPMC3912215
|
biostudies-literature
Cite
The Role of Palladin in Podocytes.
Not available
S-EPMC6054350
|
biostudies-literature
Cite
Isoform-specific upregulation of palladin in human and murine pancreas tumors.
Not available
S-EPMC2859948
|
biostudies-literature
Cite
Ablation of palladin in adult heart causes dilated cardiomyopathy associated with intercalated disc abnormalities.
Not available
S-EPMC10069870
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets